Case Control Study
Copyright ©The Author(s) 2017.
World J Gastrointest Pharmacol Ther. Nov 6, 2017; 8(4): 201-207
Published online Nov 6, 2017. doi: 10.4292/wjgpt.v8.i4.201
Table 1 Parasites observed in iodine wet mounts of cases and controls before and after concentration n (%)
Parasites observedUn concentrates
P valueFEA concentrate
P value
IBSControlsIBSControls
Blastocystis spp.16 (14.7)3 (3.0)0.0034a12 (11.0)2 (2.0)0.0112a
Cryptosporidium spp.10 (9.2)0 (0.0)0.0017a10 (9.2)0 (0.0)0.0017a
Giardia lamblia9 (8.3)1 (1.0)0.0197a12 (11.0)1 (1.0)0.0029a
Endolimax nana3 (2.8)1 (1.0)0.62283 (2.8)1 (1.0)0.6228
Entamoeba hartmanni3 (2.8)0 (0.0)0.24775 (4.6)0 (0.0)0.2477
Entamoeba histolytica/Entamoeba dipar0 (0.0)0 (0.0)10 (0.0)0 (0.0)1
Co-infections with 2 parasites2 (1.8)1 (1.0)12 (1.8)1 (1.0)1
Table 2 Blastocystis and Cryptosporidium spp. in irritable bowel syndrome patients and controls as detected by all methods n (%)
TestBlastocystis spp.
Cryptosporidium spp.
IBSControlsP valueIBSControlsP value
Iodine wet mounts14 (12.8)3 (3.0)0.0106a10 (9.2)0 (0.0)0.0017a
FEA12 (11.0)2 (2.0)0.0112a12 (11.0)0 (0.0)0.0003a
Trichrome stain14 (12.8)2 (2.0)0.0034a12 (11.0)0 (0.0)0.0003a
PCR28 (25.7)9 (9.0)0.0019a---
Acid fast stain---14 (12.8)0 (0.0)0.0001a
ELISANDND-6 (5.5)1 (1.0)0.1211